miR-122 continues to blaze the trail for microRNA therapeutics

Mol Ther. 2010 Feb;18(2):240-2. doi: 10.1038/mt.2009.313.

Authors

Dirk Haussecker¹, Mark A Kay

Affiliation

¹ Department of Pediatrics and Genetics, Stanford University, Stanford, California, USA.

No abstract available

MeSH terms

Animals
Hepatitis C / therapy
Hepatitis C / virology
Humans
MicroRNAs / genetics
MicroRNAs / metabolism*
Pan troglodytes / virology
RNA Interference

Substances

MIRN122 microRNA, human
MicroRNAs